Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cindy Kersaitis is active.

Publication


Featured researches published by Cindy Kersaitis.


Acta Neuropathologica | 2004

Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies

Cindy Kersaitis; Glenda M. Halliday; Jillian J. Kril

Frontotemporal dementia (FTD) is a prevalent neurodegenerative disease of heterogeneous histopathology. Neuropathological subtypes are identified on the basis of the presence or absence of tau- or ubiquitin-positive neuronal inclusions. Our recent work has established four disease stages that are independent of neuropathological subtype and reflect the clinical and degenerative progression observed in FTD. The variability in the extent of neuronal loss, astrogliosis, and microvacuolation are, therefore, more likely to reflect disease stage with potentially predictable differences between cases at early versus late disease stages. Understanding the variability in these parameters may assist in determining the importance of diverse disease subtypes in FTD. We examined 21 cases of sporadic, behavioural variant FTD and quantified the progression of histopathological change. The neuropathology of early disease was marked by severe astrogliosis of both the frontal and temporal cortices and neuronal loss, which was more evident in upper cortical layers of the frontal lobe. In late disease, neuronal loss was evident from both layer III and V in frontal and temporal cortices, and particularly the CA1 sector of the hippocampus. In addition, we compared the neuropathology of Pick’s disease, dementia lacking distinctive histopathology and FTD with motor neuron disease, and found no difference in these pathological subtypes on the basis of neuronal loss, astrogliosis or microvacuolation. These results show that the earliest cellular changes in FTD occur in glia, and that disease stage rather than FTD subtype determines the pattern and extent of neuronal degeneration.


Redox biology | 2013

Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells

Megan L. Steele; Stacey Fuller; Mili Patel; Cindy Kersaitis; Lezanne Ooi; Gerald Münch

Neurons rely on the release and subsequent cleavage of GSH to cysteinylglycine (CysGly) by astrocytes in order to maintain optimal intracellular GSH levels. In neurodegenerative diseases characterised by oxidative stress, neurons need an optimal GSH supply to defend themselves against free radicals released from activated microglia and astroglia. The rate of GSH synthesis is controlled largely by the activity of γ-glutamyl cysteine ligase. Expression of γ-glutamyl cysteine ligase and of the Xc- system, which facilitates cystine uptake, is regulated by the redox-sensitive transcription factor, nuclear factor erythroid-2-related factor 2 (Nrf2). Compounds that can activate the Nrf2-ARE pathway, referred to as ‘Nrf2 activators’ are receiving growing attention due to their potential as GSH-boosting drugs. This study compares four known Nrf2 activators, R-α-Lipoic acid (LA), tert-butylhydroquinone (TBHQ), sulforaphane (SFN) and Polygonum cuspidatum extract containing 50% resveratrol (PC-Res) for their effects on astroglial release of GSH and CysGly. GSH levels increased dose-dependently in response to all four drugs. Sulforaphane produced the most potent effect, increasing GSH by up to 2.4-fold. PC-Res increased GSH up to 1.6-fold, followed by TBHQ (1.5-fold) and LA (1.4-fold). GSH is processed by the ectoenzyme, γ-glutamyl transpeptidase, to form CysGly. Once again, SFN produced the most potent effect, increasing CysGly by up to 1.7-fold, compared to control cells. TBHQ and PC-Res both induced fold increases of 1.3, followed by LA with a fold increase of 1.2. The results from the present study showed that sulforaphane, followed by lipoic acid, resveratrol and Polygonum multiflorum were all identified as potent “GSH and Cys-Gly boosters”.


Annals of Neurology | 2005

Pick Bodies in a Family with Presenilin-1 Alzheimer's Disease

Glenda M. Halliday; Yun Ju C. Song; Gila Lepar; William S. Brooks; John B. Kwok; Cindy Kersaitis; Gillian C. Gregory; Claire E. Shepherd; Farid Rahimi; Peter R. Schofield; Jillian J. Kril

Presenilin‐1 (PS‐1) mutations can cause Picks disease without evidence of Alzheimers disease (AD). We describe a family with a PS‐1 M146L mutation and both Pick bodies and AD. Sarkosyl‐insoluble hyperphosphorylated tau showed three bands consistent with AD, although dephosphorylation showed primarily three‐repeat isoforms. M146L mutant PS‐1 may predispose to both Picks disease and AD by affecting multiple intracellular pathways involving tau phosphorylation and amyloid metabolism. Ann Neurol 2005;57:139–143


Neuropathology and Applied Neurobiology | 2006

Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology

Cindy Kersaitis; Glenda M. Halliday; John H. Xuereb; Roger Pamphlett; Thomas H. Bak; John R. Hodges; Jillian J. Kril

Frontotemporal lobar degeneration (FTLD) with tau‐negative, ubiquitin‐positive inclusions has been a topic of major interest in recent years, with this group now accounting for the majority of tau‐negative cases of frontotemporal degeneration. The severity of neurodegeneration in FTLD is dependent on the stage of disease and is substantial even in the earliest stages. Elucidating the pathogenesis of FTLD requires evaluation of changes during the earliest possible stage of disease. However, the long survival of most frontotemporal dementia cases means that cases with early neuropathology are not frequently encountered. Cases of FTLD with the shortest survival are those with coexisting motor neurone disease (FTLD + MND), making these the ideal group for studying early FTLD pathology. It is not clear, however, what the pathological contribution of MND is in these cases. This study evaluates the pathology of 20 cases of FTLD (11 with no clinical signs of MND and nine with FTLD + MND) as well as 10 cases of MND without dementia. Our findings indicate that the deposition of ubiquitin does not play a key role in the neurodegenerative process in FTLD, and that the severity of neurodegeneration in FTLD is similar in cases with and without clinical MND.


PLOS ONE | 2013

Vitamin D2-Enriched Button Mushroom (Agaricus bisporus) Improves Memory in Both Wild Type and APPswe/PS1dE9 Transgenic Mice

Louise Bennett; Cindy Kersaitis; S L Macaulay; Gerald Münch; Garry Niedermayer; Julie Nigro; Matthew Payne; Paul Sheean; Pascal Vallotton; Dimitrios Zabaras; Michael Bird

Vitamin D deficiency is widespread, affecting over 30% of adult Australians, and increasing up to 80% for at-risk groups including the elderly (age>65). The role for Vitamin D in development of the central nervous system is supported by the association between Vitamin D deficiency and incidence of neurological and psychiatric disorders including Alzheimer’s disease (AD). A reported positive relationship between Vitamin D status and cognitive performance suggests that restoring Vitamin D status might provide a cognitive benefit to those with Vitamin D deficiency. Mushrooms are a rich source of ergosterol, which can be converted to Vitamin D2 by treatment with UV light, presenting a new and convenient dietary source of Vitamin D2. We hypothesised that Vitamin D2-enriched mushrooms (VDM) could prevent the cognitive and pathological abnormalities associated with dementia. Two month old wild type (B6C3) and AD transgenic (APPSwe/PS1dE9) mice were fed a diet either deficient in Vitamin D2 or a diet which was supplemented with VDM, containing 1±0.2 µg/kg (∼54 IU/kg) vitamin D2, for 7 months. Effects of the dietary intervention on memory were assessed pre- and post-feeding. Brain sections were evaluated for amyloid β (Aβ) plaque loads and inflammation biomarkers using immuno-histochemical methods. Plasma vitamin D metabolites, Aβ40, Aβ42, calcium, protein and cholesterol were measured using biochemical assays. Compared with mice on the control diet, VDM-fed wild type and AD transgenic mice displayed improved learning and memory, had significantly reduced amyloid plaque load and glial fibrillary acidic protein, and elevated interleukin-10 in the brain. The results suggest that VDM might provide a dietary source of Vitamin D2 and other bioactives for preventing memory-impairment in dementia. This study supports the need for a randomised clinical trial to determine whether or not VDM consumption can benefit cognitive performance in the wider population.


International Journal of Photochemistry | 2014

Photocatalysis of Titanium Dioxide for Water Disinfection: Challenges and Future Perspectives

Ming J. Wu; T. Bak; Michelle C. Moffitt; Janusz Nowotny; Trevor D. Bailey; Cindy Kersaitis

The performance of metal oxides such as titanium dioxide (TiO2), in the conversion of solar energy into chemical energy, is determined by semiconducting properties. The conversion process is closely related to the light-induced reactivity between oxide semiconductors and water, which may lead to partial water oxidation and consequently water disinfection. Key performance-related properties are considered here, including light absorption, light-induced ionisation over the band gap, charge separation, charge transport, charge transfer, and the chemical reactions taking place at anodic and cathodic sites. Optimisation of these interconnected performance-related properties is discussed, along with the photocatalytic application in water disinfection.


Letters in Applied Microbiology | 2015

Effects of metal ions and hydrogen peroxide on the phenotype of yeast hom6Δ mutant

Nay M. Tun; B.R. Lennon; Patrick J. O'Doherty; A.J. Johnson; G. Petersingham; Trevor D. Bailey; Cindy Kersaitis; Ming J. Wu

HOM6 is a major gene in the aspartate pathway which leads to biosynthesis of threonine and methionine. The phenotypes of the gene deletion mutant (hom6∆) in a variety of cultural conditions have previously provided meaningful insights into the biological roles of HOM6 and its upstream intermediate metabolites. Here, we conducted a survey on a spectrum of metal ions for their effect on the aspartate pathway and broader sulphur metabolism. We show that manganese (Mn2+) promoted the growth of hom6∆ under both anaerobic and aerobic conditions. Unexpectedly, 4 mmol l−1 hydrogen peroxide (H2O2), a dose normally causing temporary cell growth arrest, enhanced the growth of hom6∆ under the anaerobic condition only, while it had no effect on the wild type strain BY4743. We propose that Mn2+ and H2O2 promote the growth of hom6∆ by reducing the accumulation of the toxic intermediate metabolite—aspartate β‐semialdehyde, via directing the aspartate pathway to the central sugar metabolism–tricarboxylic acid cycle.


Brain | 2003

Severity of gliosis in Pick’s disease and frontotemporal lobar degeneration: tau‐positive glia differentiate these disorders

Emma C. Schofield; Cindy Kersaitis; Claire E. Shepherd; Jillian J. Kril; Glenda M. Halliday


Cellular and Molecular Neurobiology | 2013

Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells

Megan L. Steele; Stacey Fuller; Annette Maczurek; Cindy Kersaitis; Lezanne Ooi; Gerald Münch


Metallomics | 2014

Identification of aluminium transport-related genes via genome-wide phenotypic screening of Saccharomyces cerevisiae

Nay M. Tun; Patrick J. O'Doherty; Zhong-Hua Chen; Xi-Yang Wu; Trevor D. Bailey; Cindy Kersaitis; Ming J. Wu

Collaboration


Dive into the Cindy Kersaitis's collaboration.

Top Co-Authors

Avatar

Ming J. Wu

University of Western Sydney

View shared research outputs
Top Co-Authors

Avatar

Trevor D. Bailey

University of Western Sydney

View shared research outputs
Top Co-Authors

Avatar

Patrick J. O'Doherty

University of Western Sydney

View shared research outputs
Top Co-Authors

Avatar

Gerald Münch

University of Western Sydney

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Megan L. Steele

Queensland University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nay M. Tun

University of Western Sydney

View shared research outputs
Researchain Logo
Decentralizing Knowledge